Straits Times Index
3,307.90 -6.15 (-0.19%) S&P 500
5,305.57 -2.56 (-0.05%) Dow
39,849.35 +42.58 (+0.11%) Nasdaq
16,756.12 -38.76 (-0.23%) Bitcoin USD
70,586.26 +3,481.03 (+5.19%) CMC Crypto 200
1,541.44 +52.90 (+3.55%)
Nestlé S.A. (NESN.SW)
| Previous close | 96.62 |
| Open | 96.70 |
| Bid | 95.76 x 0 |
| Ask | 95.78 x 0 |
| Day's range | 95.34 - 96.80 |
| 52-week range | 89.52 - 113.28 |
| Volume | |
| Avg. volume | 4,277,473 |
| Market cap | 250.891B |
| Beta (5Y monthly) | 0.29 |
| PE ratio (TTM) | 22.64 |
| EPS (TTM) | 4.23 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 3.00 (3.10%) |
| Ex-dividend date | 22 Apr 2024 |
| 1y target est | 108.68 |
ReutersNestle set to sell $5 pizza, sandwiches for Wegovy, Ozempic users
Nestle will market a new, $5 line of frozen pizzas and protein-enriched pastas in the United States which it says it designed specifically for people taking drugs such as Wegovy or Ozempic for weight loss. The world's biggest food company, which sells DiGiorno pizza and Stouffer's meals to major grocers, said it developed the new products with more protein, iron and calcium for people taking the wildly popular appetite-suppressing drugs, called GLP-1 agonists. Tom Moe, president of Nestle USA's meal division, said it will pitch the meals in a new brand, Vital Pursuit, as "food solutions" for people who want to complement their use of the drugs with "the right nutrition - high protein, good fiber, the right minerals," like potassium and vitamin C.
CNN BusinessNestlé is releasing a lineup of frozen food for people on Ozempic and other GLP-1 drugs
Nestlé, the maker of frozen food brands like Stouffer’s and DiGiorno, is slimming down with a new line of food for people taking GLP-1 drugs, such as Ozempic, for weight loss.
Barrons.comBuy Nestlé Stock. Despair Is Turning to Hope.
The world’s largest food company has been a sleeping giant. It’s waking up—making its shares attractive once again.
